首页> 中文期刊> 《河北医药 》 >EGCG 对5-氟尿嘧啶用于食管癌 CaEs-17细胞增加疗效的实验研究

EGCG 对5-氟尿嘧啶用于食管癌 CaEs-17细胞增加疗效的实验研究

             

摘要

目的:观察表没食子儿茶素没食子酸酯(EGCG)体外增强5-氟尿嘧啶(5-Fu)对食管癌CaEs-17细胞化疗敏感性的作用,并探讨可能的作用机制。方法实验分为空白对照组、5-Fu 组(培养液中5-Fu 终浓度为6μmol/L),EGCG组(培养液中EGCG终浓度为20 mg/L)、联合组(培养液中EGCG终浓度为20 mg/L,5-Fu浓度为6μmol/L),4组作用24 h,CCK-8法和细胞克隆形成法检测细胞增殖抑制率和存活率,金氏公式评价二药的协同效果;流式细胞仪检测细胞凋亡率及周期分布;Transwell法检测细胞侵袭力;免疫印迹法检测突变型P53(mtP53)蛋白表达水平。结果 EGCG、5-Fu均可抑制CaEs-17细胞增殖、诱导细胞凋亡、降低细胞存活率和侵袭力;EGCG、5-Fu均可阻滞细胞于G0/G1期,并能下调mtP53蛋白表达水平( P <0.05),二药联用上述作用效果更为显著( P <0.01)。结论 EGCG能够增强5-Fu对食管癌CaEs-17细胞的化疗敏感性,这种作用部分是通过下调mtP53蛋白实现的。%Objective To observe the effect of epigallocatechin-3-gallate ( EGCG ) in enhancing chemotherapy sensitivity of 5-fluorouracil ( 5-Fu ) on human esophageal cancer line-CaEs-17 in vitro, and to explore possible action mechanism.Methods The experiment consisted of four groups:blank control group,5-Fu group ( final concentration of 5-Fu:6μmol/L in culture medium),EGCG group (final concentration of EGCG:20mg/L),combination group (final concentration of EGCG:20mg/L and 5-Fu:6μmol/L),affected for 24 hours in four groups.The inhibitory rate on cell proliferation and survival rate were detected by CCK-8 method and cell clone formation test,respevtively;the synergism effect of two drugs was evaluated according to Jin’ s formula;the cell apoptosis rate and cell cycle distribution were detected by flow cytometry;cell invasiveness was determined by Transwell method;the expression levels of mutant P53 (mtP53) protein were detected by Western Blot. Results Both EGCG and 5-Fu could inhibit the proliferation of CaEs-17 cells,induce cell apoptosis ,decrease cell survival rate and cell invasiveness, moreover, both EGCG and 5-Fu could block cell at G0/G1 stage and cloud down-regulate the expression levels of mtP53 protein ( P <0.05),the effects of combined application of two drugs were more obvious ( P <0.01).Conclusion EGCG can enhance chemotherapy sensitivity of 5-Fu on human esophageal cancer line-CaEs-17 in vitro, which is performed partly through down-regulating the expression levels of mutation P53 protein.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号